P. C. Brandt, G. C.-Y. Chiou (Head), G. D. Frye,
W. H. Griffith III, R. K. Hester, B. A. McCool, A. R. Parrish,
J. P. Trzeciakowski, J. L. Way, U. Winzer-Serhan
(MPHM)
603. Neuropsychopharmacology.
(4-0). Credit 4.
Interaction of drugs and toxins
with neurotransmitter systems; emphasis on mechanisms involving
receptor function that impact central nervous system. Prerequisites:
Approval of coordinator.
605. Molecular Mechanisms
of Drug and Toxin Action I. (4-0). Credit 4.
Introduction to the major tools
and concepts of pharmacology; selectivity of drug action determined
by pharmacological principles; scientific basis for a rational
approach to the study of drug actions and side effects. Prerequisite:
Approval of coordinator.
606. Molecular Mechanisms
of Drug and Toxin Action II. (4-0). Credit 4.
Introduction to drug receptor
interaction theory, concepts of agonist, antagonist, affinity
and efficacy, and molecular signaling mechanisms; overview
of toxicants and of toxicity including carcinogenesis and endocrine
disruption; survey of ocular drugs. Prerequisite: Approval
of coordinator.
607. Molecular Mechanisms
of Drug and Toxin Action III. (4-0). Credit 4.
Interaction of drugs and toxins
with neurotransmitter systems; emphasis on mechanisms involving
receptor function that impact central nervous system integration.
Prerequisite: Approval of instructor.
923. Medical Pharmacology
I. (3-0). Credit 3.
General concepts of pharmacological
agents and substances; pharmacokinetics, pharmacodynamics;
autonomic drugs; ocular pharmacology and cardiovascular pharmacology.
Prerequisites: Admission to medical curriculum or MANA 922;
MBCH 911 or approval of department head; MPHY 901.
924. Medical Pharmacology
II. (4-3). Credit 4.
Continuation of MPHM 923; anesthetics;
neuro-psychopharmacology; analgesics; chemotherapy, endocrine
pharamcology; autacoids; drug abuse and medical toxicology.
Prerequisite: MPHM 923.
